Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

ESMO – CSCO Collaborative Session: Drug prioritisation and support of biomarkers

Development of biomarker driven clinical studies in China

Date

22 Nov 2019

Session

ESMO – CSCO Collaborative Session: Drug prioritisation and support of biomarkers

Topics

Cytotoxic Therapy

Tumour Site

Presenters

Xiaotian Zhang

Authors

X. Zhang

Author affiliations

  • Department Of Gastrointestinal Oncology, Peking University Cancer Hospital-Beijing Cancer Hospital, 100142 - Beijing/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.